Literature DB >> 23855681

Investigating chromosome damage using fluorescent in situ hybridization to identify biomarkers of radiosensitivity in prostate cancer patients.

Lindsay A Beaton1, Leonora Marro, Sara Samiee, Shawn Malone, Scott Grimes, Kyle Malone, Ruth C Wilkins.   

Abstract

PURPOSE: In order to evaluate fluorescent in situ hybridization (FISH) as a method for predicting radiosensitivity, this study examined the incidence of translocations, after exposure to in vitro radiation, in both normally responding patients and those exhibiting severe late effects after radiotherapy treatment.
MATERIALS AND METHODS: Patients were selected from a randomized trial for intermediate-risk prostate cancer. Of the patients entered on trial with mature follow-up, 3% developed grade 3 late proctitis. Blood samples were taken from this radiosensitive cohort along with matched control patients with no late proctitis. Whole blood samples were exposed to 0 or 4 Gy and cultured according to the International Atomic Energy Agency (IAEA) recommended methods. Colour junctions were evaluated in the resulting metaphases and scored according to the Protocol for Aberration Identification and Nomenclature Terminology (PAINT) system.
RESULTS: Both groups were statistically similar at 0 Gy. After 4 Gy in vitro radiation, the radiosensitive group had significantly higher rates of chromosome damage in the number of colour junctions per cell (p = 0.002), the number of deletions per cell (p = 0.01) and the number of dicentrics per cell (p = 0.005).
CONCLUSIONS: These results indicate that the analysis of translocations using FISH after in vitro irradiation correlates with clinical response to radiation. This cytogenetic assay should be considered as a potential predictor of radiosensitivity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23855681     DOI: 10.3109/09553002.2013.825060

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  9 in total

1.  Dicentric Dose Estimates for Patients Undergoing Radiotherapy in the RTGene Study to Assess Blood Dosimetric Models and the New Bayesian Method for Gradient Exposure.

Authors:  Jayne Moquet; Manuel Higueras; Ellen Donovan; Sue Boyle; Stephen Barnard; Clare Bricknell; Mingzhu Sun; Lone Gothard; Grainne O'Brien; Lourdes Cruz-Garcia; Christophe Badie; Elizabeth Ainsbury; Navita Somaiah
Journal:  Radiat Res       Date:  2018-09-20       Impact factor: 2.841

Review 2.  Molecular contribution of BRCA1 and BRCA2 to genome instability in breast cancer patients: review of radiosensitivity assays.

Authors:  Fatemeh Sadeghi; Marzieh Asgari; Mojdeh Matloubi; Maral Ranjbar; Nahid Karkhaneh Yousefi; Tahereh Azari; Majid Zaki-Dizaji
Journal:  Biol Proced Online       Date:  2020-10-01       Impact factor: 3.244

3.  Radioprotectors and Radiomitigators for Improving Radiation Therapy: The Small Business Innovation Research (SBIR) Gateway for Accelerating Clinical Translation.

Authors:  Pataje G S Prasanna; Deepa Narayanan; Kory Hallett; Eric J Bernhard; Mansoor M Ahmed; Gregory Evans; Bhadrasain Vikram; Michael Weingarten; C Norman Coleman
Journal:  Radiat Res       Date:  2015-08-18       Impact factor: 2.841

4.  Investigation of Chromosome 1 Aberrations in the Lymphocytes of Prostate Cancer and Benign Prostatic Hyperplasia Patients by Fluorescence in situ Hybridization.

Authors:  Justyna Miszczyk; Mikołaj Przydacz; Michał Zembrzuski; Piotr L Chłosta
Journal:  Cancer Manag Res       Date:  2021-05-31       Impact factor: 3.989

5.  Differential Radiosensitizing Effect of 50 nm Gold Nanoparticles in Two Cancer Cell Lines.

Authors:  Miguel Ángel Pérez-Amor; Leonardo Barrios; Gemma Armengol; Joan Francesc Barquinero
Journal:  Biology (Basel)       Date:  2022-08-09

6.  Aberrations Involving Chromosome 1 as a Possible Predictor of Odds Ratio for Colon Cancer--Results from the Krakow Case-Control Study.

Authors:  Aleksander Galas; Justyna Miszczyk
Journal:  PLoS One       Date:  2016-01-29       Impact factor: 3.240

Review 7.  Clinical and Functional Assays of Radiosensitivity and Radiation-Induced Second Cancer.

Authors:  Mohammad Habash; Luis C Bohorquez; Elizabeth Kyriakou; Tomas Kron; Olga A Martin; Benjamin J Blyth
Journal:  Cancers (Basel)       Date:  2017-10-27       Impact factor: 6.639

8.  Rate of individuals with clearly increased radiosensitivity rise with age both in healthy individuals and in cancer patients.

Authors:  Barbara Schuster; Anna Ellmann; Theresa Mayo; Judith Auer; Matthias Haas; Markus Hecht; Rainer Fietkau; Luitpold V Distel
Journal:  BMC Geriatr       Date:  2018-05-04       Impact factor: 3.921

9.  Is in vivo and ex vivo irradiation equally reliable for individual Radiosensitivity testing by three colour fluorescence in situ hybridization?

Authors:  Theresa Mayo; Marlen Haderlein; Barbara Schuster; Anna Wiesmüller; Christian Hummel; Maximilian Bachl; Manfred Schmidt; Rainer Fietkau; Luitpold Distel
Journal:  Radiat Oncol       Date:  2019-12-31       Impact factor: 3.481

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.